APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Albumin (as Excipient)

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Selected research

Industry Growth & Trends

Global Albumin (as Excipient) Industry Growth and Trends Forecast to 2032

Report ID 17396156011 January 2026100 pages

Choose your research edition.

Industry ResearchAlbumin (as Excipient) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Albumin (as Excipient) Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Albumin (as Excipient) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albumin (as Excipient) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Albumin (as Excipient) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Albumin (as Excipient) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Albumin (as Excipient) market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Albumin (as Excipient) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Albumin (as Excipient).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Albumin (as Excipient) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Albumin (as Excipient) Market by Company

CSL

Grifols

Takeda

Octapharma

Hualan Bio

CBPO

Shanghai RAAS

Kedrion

LFB Group

Albumedix

Biotest

Merck

Ventria (InVitria)

HiMedia

Albumin (as Excipient) Segment by Type

Human Serum Albumin

Recombinant Albumin

Albumin (as Excipient) Segment by Application

Cell Culture Media

Medical Supplements

Therapeutics

Albumin (as Excipient) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin (as Excipient) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albumin (as Excipient) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin (as Excipient).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Albumin (as Excipient) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Serum Albumin Table 2. Major Company of Recombinant Albumin Table 3. Global Albumin (as Excipient) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Albumin (as Excipient) Sales by Type (2021-2026) & (MT) Table 5. Global Albumin (as Excipient) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Albumin (as Excipient) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Albumin (as Excipient) Sales Market Share in Value by Type (2021-2026) Table 8. Global Albumin (as Excipient) Price by Type (2021-2026) & (USD/Kg) Table 9. Global Albumin (as Excipient) Sales by Type (2027-2032) & (MT) Table 10. Global Albumin (as Excipient) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Albumin (as Excipient) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Albumin (as Excipient) Sales Market Share in Value by Type (2027-2032) Table 13. Global Albumin (as Excipient) Price by Type (2027-2032) & (USD/Kg) Table 14. North America Albumin (as Excipient) Sales by Type (2021-2026) & (MT) Table 15. North America Albumin (as Excipient) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Albumin (as Excipient) Sales by Type (2021-2026) & (MT) Table 17. Europe Albumin (as Excipient) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Albumin (as Excipient) Sales by Type (2021-2026) & (MT) Table 19. Asia-Pacific Albumin (as Excipient) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Albumin (as Excipient) Sales by Type (2021-2026) & (MT) Table 21. Latin America Albumin (as Excipient) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Albumin (as Excipient) Sales by Type (2021-2026) & (MT) Table 23. Middle East and Africa Albumin (as Excipient) Sales by Type (2021-2026) & (US$ Million) Table 24. Albumin (as Excipient) Industry Trends Table 25. Albumin (as Excipient) Industry Drivers Table 26. Albumin (as Excipient) Industry Opportunities and Challenges Table 27. Albumin (as Excipient) Industry Restraints Table 28. Global Albumin (as Excipient) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Albumin (as Excipient) Revenue Market Share by Company (2021-2026) Table 30. Global Albumin (as Excipient) Sales by Company (2021-2026) & (MT) Table 31. Global Albumin (as Excipient) Sales Share by Company (2021-2026) Table 32. Global Albumin (as Excipient) Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Albumin (as Excipient) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Albumin (as Excipient) Major Company Production Sites and Headquarters Table 35. Global Albumin (as Excipient) Company, Product Type & Application Table 36. Global Albumin (as Excipient) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Albumin (as Excipient) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Albumin (as Excipient) Sales by Region (2021-2026) & (MT) Table 41. Global Albumin (as Excipient) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Albumin (as Excipient) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Albumin (as Excipient) Sales Market Share in Value by Region (2021-2026) Table 44. Global Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Albumin (as Excipient) Sales by Region (2027-2032) & (MT) Table 46. Global Albumin (as Excipient) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Albumin (as Excipient) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Albumin (as Excipient) Sales Market Share in Value by Region (2027-2032) Table 49. Global Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Albumin (as Excipient) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Albumin (as Excipient) Sales by Application (2021-2026) & (MT) Table 52. Global Albumin (as Excipient) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Albumin (as Excipient) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Albumin (as Excipient) Sales Market Share in Value by Application (2021-2026) Table 55. Global Albumin (as Excipient) Price by Application (2021-2026) & (USD/Kg) Table 56. Global Albumin (as Excipient) Sales by Application (2027-2032) & (MT) Table 57. Global Albumin (as Excipient) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Albumin (as Excipient) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Albumin (as Excipient) Sales Market Share in Value by Application (2027-2032) Table 60. Global Albumin (as Excipient) Price by Application (2027-2032) & (USD/Kg) Table 61. North America Albumin (as Excipient) Sales by Application (2021-2026) & (MT) Table 62. North America Albumin (as Excipient) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Albumin (as Excipient) Sales by Application (2021-2026) & (MT) Table 64. Europe Albumin (as Excipient) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Albumin (as Excipient) Sales by Application (2021-2026) & (MT) Table 66. Asia-Pacific Albumin (as Excipient) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Albumin (as Excipient) Sales by Application (2021-2026) & (MT) Table 68. Latin America Albumin (as Excipient) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Albumin (as Excipient) Sales by Application (2021-2026) & (MT) Table 70. Middle East and Africa Albumin (as Excipient) Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Company Information Table 72. CSL Business Overview Table 73. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. CSL Albumin (as Excipient) Product Portfolio Table 75. CSL Recent Development Table 76. Grifols Company Information Table 77. Grifols Business Overview Table 78. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Grifols Albumin (as Excipient) Product Portfolio Table 80. Grifols Recent Development Table 81. Takeda Company Information Table 82. Takeda Business Overview Table 83. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Takeda Albumin (as Excipient) Product Portfolio Table 85. Takeda Recent Development Table 86. Octapharma Company Information Table 87. Octapharma Business Overview Table 88. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Octapharma Albumin (as Excipient) Product Portfolio Table 90. Octapharma Recent Development Table 91. Hualan Bio Company Information Table 92. Hualan Bio Business Overview Table 93. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Hualan Bio Albumin (as Excipient) Product Portfolio Table 95. Hualan Bio Recent Development Table 96. CBPO Company Information Table 97. CBPO Business Overview Table 98. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. CBPO Albumin (as Excipient) Product Portfolio Table 100. CBPO Recent Development Table 101. Shanghai RAAS Company Information Table 102. Shanghai RAAS Business Overview Table 103. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Shanghai RAAS Albumin (as Excipient) Product Portfolio Table 105. Shanghai RAAS Recent Development Table 106. Kedrion Company Information Table 107. Kedrion Business Overview Table 108. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Kedrion Albumin (as Excipient) Product Portfolio Table 110. Kedrion Recent Development Table 111. LFB Group Company Information Table 112. LFB Group Business Overview Table 113. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. LFB Group Albumin (as Excipient) Product Portfolio Table 115. LFB Group Recent Development Table 116. Albumedix Company Information Table 117. Albumedix Business Overview Table 118. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. Albumedix Albumin (as Excipient) Product Portfolio Table 120. Albumedix Recent Development Table 121. Biotest Company Information Table 122. Biotest Business Overview Table 123. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. Biotest Albumin (as Excipient) Product Portfolio Table 125. Biotest Recent Development Table 126. Merck Company Information Table 127. Merck Business Overview Table 128. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 129. Merck Albumin (as Excipient) Product Portfolio Table 130. Merck Recent Development Table 131. Ventria (InVitria) Company Information Table 132. Ventria (InVitria) Business Overview Table 133. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 134. Ventria (InVitria) Albumin (as Excipient) Product Portfolio Table 135. Ventria (InVitria) Recent Development Table 136. HiMedia Company Information Table 137. HiMedia Business Overview Table 138. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 139. HiMedia Albumin (as Excipient) Product Portfolio Table 140. HiMedia Recent Development Table 141. North America Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 142. North America Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 143. North America Albumin (as Excipient) Sales Market Share by Country (2021-2026) Table 144. North America Albumin (as Excipient) Sales Forecast by Country (2027-2032) & (MT) Table 145. North America Albumin (as Excipient) Sales Market Share Forecast by Country (2027-2032) Table 146. North America Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Albumin (as Excipient) Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Albumin (as Excipient) Market Share by Country (2021-2026) Table 149. North America Albumin (as Excipient) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Albumin (as Excipient) Market Share Forecast by Country (2027-2032) Table 151. Europe Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 152. Europe Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 153. Europe Albumin (as Excipient) Sales Market Share by Country (2021-2026) Table 154. Europe Albumin (as Excipient) Sales Forecast by Country (2027-2032) & (MT) Table 155. Europe Albumin (as Excipient) Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Albumin (as Excipient) Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Albumin (as Excipient) Market Share by Country (2021-2026) Table 159. Europe Albumin (as Excipient) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Albumin (as Excipient) Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 163. Asia-Pacific Albumin (as Excipient) Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Albumin (as Excipient) Sales Forecast by Country (2027-2032) & (MT) Table 165. Asia-Pacific Albumin (as Excipient) Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Albumin (as Excipient) Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Albumin (as Excipient) Market Share by Country (2021-2026) Table 169. Asia-Pacific Albumin (as Excipient) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Albumin (as Excipient) Market Share Forecast by Country (2027-2032) Table 171. Latin America Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 172. Latin America Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 173. Latin America Albumin (as Excipient) Sales Market Share by Country (2021-2026) Table 174. Latin America Albumin (as Excipient) Sales Forecast by Country (2027-2032) & (MT) Table 175. Latin America Albumin (as Excipient) Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Albumin (as Excipient) Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Albumin (as Excipient) Market Share by Country (2021-2026) Table 179. Latin America Albumin (as Excipient) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Albumin (as Excipient) Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 183. Middle East and Africa Albumin (as Excipient) Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Albumin (as Excipient) Sales Forecast by Country (2027-2032) & (MT) Table 185. Middle East and Africa Albumin (as Excipient) Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Albumin (as Excipient) Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Albumin (as Excipient) Market Share by Country (2021-2026) Table 189. Middle East and Africa Albumin (as Excipient) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Albumin (as Excipient) Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Albumin (as Excipient) Distributors List Table 194. Albumin (as Excipient) Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Albumin (as Excipient) Image Figure 2. Global Albumin (as Excipient) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albumin (as Excipient) Market Size (2021-2032) & (US$ Million) Figure 4. Global Albumin (as Excipient) Sales (2021-2032) & (MT) Figure 5. Human Serum Albumin Image Figure 6. Global Human Serum Albumin Sales YoY Growth (2021-2032) & (MT) Figure 7. Recombinant Albumin Image Figure 8. Global Recombinant Albumin Sales YoY Growth (2021-2032) & (MT) Figure 9. Global Albumin (as Excipient) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Albumin (as Excipient) Market Share by Type 2025 VS 2032 Figure 11. North America Albumin (as Excipient) Sales Market Share in Volume by Type in 2025 Figure 12. North America Albumin (as Excipient) Sales Market Share in Value by Type in 2025 Figure 13. Europe Albumin (as Excipient) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Albumin (as Excipient) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Albumin (as Excipient) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Albumin (as Excipient) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Albumin (as Excipient) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Albumin (as Excipient) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Albumin (as Excipient) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Albumin (as Excipient) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Albumin (as Excipient) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cell Culture Media Image Figure 24. Global Cell Culture Media Sales YoY Growth (2021-2032) & (MT) Figure 25. Medical Supplements Image Figure 26. Global Medical Supplements Sales YoY Growth (2021-2032) & (MT) Figure 27. Therapeutics Image Figure 28. Global Therapeutics Sales YoY Growth (2021-2032) & (MT) Figure 29. Global Albumin (as Excipient) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Albumin (as Excipient) Market Share by Application 2025 VS 2032 Figure 31. North America Albumin (as Excipient) Sales Market Share in Volume by Application in 2025 Figure 32. North America Albumin (as Excipient) Sales Market Share in Value by Application in 2025 Figure 33. Europe Albumin (as Excipient) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Albumin (as Excipient) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Albumin (as Excipient) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Albumin (as Excipient) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Albumin (as Excipient) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Albumin (as Excipient) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Albumin (as Excipient) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Albumin (as Excipient) Sales Market Share in Value by Application in 2025 Figure 41. North America Albumin (as Excipient) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 42. North America Albumin (as Excipient) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Albumin (as Excipient) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Albumin (as Excipient) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Albumin (as Excipient) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 46. Europe Albumin (as Excipient) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Albumin (as Excipient) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Albumin (as Excipient) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Albumin (as Excipient) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 50. Asia-Pacific Albumin (as Excipient) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Albumin (as Excipient) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Albumin (as Excipient) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Albumin (as Excipient) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 54. Latin America Albumin (as Excipient) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Albumin (as Excipient) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Albumin (as Excipient) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Albumin (as Excipient) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 58. Middle East and Africa Albumin (as Excipient) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Albumin (as Excipient) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Albumin (as Excipient) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Albumin (as Excipient) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Albumin (as Excipient) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Human Serum Albumin
  • Recombinant Albumin
Applications
  • Cell Culture Media
  • Medical Supplements
  • Therapeutics
Companies covered
  • CSL
  • Grifols
  • Takeda
  • Octapharma
  • Hualan Bio
  • CBPO
  • Shanghai RAAS
  • Kedrion
  • LFB Group
  • Albumedix
  • Biotest
  • Merck
  • Ventria (InVitria)
  • HiMedia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albumin (as Excipient) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Albumin (as Excipient) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Albumin (as Excipient) Market by Type
  6. 1.3.1 Human Serum Albumin
  7. 1.3.2 Recombinant Albumin
  8. 1.4 Global Albumin (as Excipient) Market Size by Type
  9. 1.4.1 Global Albumin (as Excipient) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Albumin (as Excipient) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Albumin (as Excipient) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Albumin (as Excipient) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Albumin (as Excipient) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Albumin (as Excipient) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Albumin (as Excipient) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Albumin (as Excipient) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Albumin (as Excipient) Industry Trends
  2. 2.2 Albumin (as Excipient) Industry Drivers
  3. 2.3 Albumin (as Excipient) Industry Opportunities and Challenges
  4. 2.4 Albumin (as Excipient) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Albumin (as Excipient) Revenue (2021-2026)
  2. 3.2 Global Top Players by Albumin (as Excipient) Sales (2021-2026)
  3. 3.3 Global Top Players by Albumin (as Excipient) Price (2021-2026)
  4. 3.4 Global Albumin (as Excipient) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albumin (as Excipient) Major Company Production Sites & Headquarters
  6. 3.6 Global Albumin (as Excipient) Company, Product Type & Application
  7. 3.7 Global Albumin (as Excipient) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albumin (as Excipient) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albumin (as Excipient) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albumin (as Excipient) Tier 1, Tier 2, and Tier 3
4 Albumin (as Excipient) Regional Status and Outlook
  1. 4.1 Global Albumin (as Excipient) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Albumin (as Excipient) Historic Market Size by Region
  3. 4.2.1 Global Albumin (as Excipient) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Albumin (as Excipient) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Albumin (as Excipient) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Albumin (as Excipient) Forecasted Market Size by Region
  7. 4.3.1 Global Albumin (as Excipient) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Albumin (as Excipient) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Albumin (as Excipient) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Albumin (as Excipient) by Application
  1. 5.1 Albumin (as Excipient) Market by Application
  2. 5.1.1 Cell Culture Media
  3. 5.1.2 Medical Supplements
  4. 5.1.3 Therapeutics
  5. 5.2 Global Albumin (as Excipient) Market Size by Application
  6. 5.2.1 Global Albumin (as Excipient) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Albumin (as Excipient) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Albumin (as Excipient) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Albumin (as Excipient) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Albumin (as Excipient) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Albumin (as Excipient) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Albumin (as Excipient) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Albumin (as Excipient) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL
  2. 6.1.1 CSL Company Information
  3. 6.1.2 CSL Business Overview
  4. 6.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Albumin (as Excipient) Product Portfolio
  6. 6.1.5 CSL Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Albumin (as Excipient) Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 Takeda
  14. 6.3.1 Takeda Company Information
  15. 6.3.2 Takeda Business Overview
  16. 6.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Takeda Albumin (as Excipient) Product Portfolio
  18. 6.3.5 Takeda Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Albumin (as Excipient) Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Hualan Bio
  26. 6.5.1 Hualan Bio Company Information
  27. 6.5.2 Hualan Bio Business Overview
  28. 6.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hualan Bio Albumin (as Excipient) Product Portfolio
  30. 6.5.5 Hualan Bio Recent Developments
  31. 6.6 CBPO
  32. 6.6.1 CBPO Company Information
  33. 6.6.2 CBPO Business Overview
  34. 6.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CBPO Albumin (as Excipient) Product Portfolio
  36. 6.6.5 CBPO Recent Developments
  37. 6.7 Shanghai RAAS
  38. 6.7.1 Shanghai RAAS Company Information
  39. 6.7.2 Shanghai RAAS Business Overview
  40. 6.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai RAAS Albumin (as Excipient) Product Portfolio
  42. 6.7.5 Shanghai RAAS Recent Developments
  43. 6.8 Kedrion
  44. 6.8.1 Kedrion Company Information
  45. 6.8.2 Kedrion Business Overview
  46. 6.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kedrion Albumin (as Excipient) Product Portfolio
  48. 6.8.5 Kedrion Recent Developments
  49. 6.9 LFB Group
  50. 6.9.1 LFB Group Company Information
  51. 6.9.2 LFB Group Business Overview
  52. 6.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 LFB Group Albumin (as Excipient) Product Portfolio
  54. 6.9.5 LFB Group Recent Developments
  55. 6.10 Albumedix
  56. 6.10.1 Albumedix Company Information
  57. 6.10.2 Albumedix Business Overview
  58. 6.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Albumedix Albumin (as Excipient) Product Portfolio
  60. 6.10.5 Albumedix Recent Developments
  61. 6.11 Biotest
  62. 6.11.1 Biotest Company Information
  63. 6.11.2 Biotest Business Overview
  64. 6.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biotest Albumin (as Excipient) Product Portfolio
  66. 6.11.5 Biotest Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Albumin (as Excipient) Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Ventria (InVitria)
  74. 6.13.1 Ventria (InVitria) Company Information
  75. 6.13.2 Ventria (InVitria) Business Overview
  76. 6.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ventria (InVitria) Albumin (as Excipient) Product Portfolio
  78. 6.13.5 Ventria (InVitria) Recent Developments
  79. 6.14 HiMedia
  80. 6.14.1 HiMedia Company Information
  81. 6.14.2 HiMedia Business Overview
  82. 6.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 HiMedia Albumin (as Excipient) Product Portfolio
  84. 6.14.5 HiMedia Recent Developments
7 North America by Country
  1. 7.1 North America Albumin (as Excipient) Sales by Country
  2. 7.1.1 North America Albumin (as Excipient) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Albumin (as Excipient) Sales by Country (2021-2026)
  4. 7.1.3 North America Albumin (as Excipient) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Albumin (as Excipient) Market Size by Country
  6. 7.2.1 North America Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Albumin (as Excipient) Market Size by Country (2021-2026)
  8. 7.2.3 North America Albumin (as Excipient) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Albumin (as Excipient) Sales by Country
  2. 8.1.1 Europe Albumin (as Excipient) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Albumin (as Excipient) Sales by Country (2021-2026)
  4. 8.1.3 Europe Albumin (as Excipient) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Albumin (as Excipient) Market Size by Country
  6. 8.2.1 Europe Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Albumin (as Excipient) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Albumin (as Excipient) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Albumin (as Excipient) Sales by Country
  2. 9.1.1 Asia-Pacific Albumin (as Excipient) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Albumin (as Excipient) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Albumin (as Excipient) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Albumin (as Excipient) Market Size by Country
  6. 9.2.1 Asia-Pacific Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Albumin (as Excipient) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Albumin (as Excipient) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Albumin (as Excipient) Sales by Country
  2. 10.1.1 South America Albumin (as Excipient) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Albumin (as Excipient) Sales by Country (2021-2026)
  4. 10.1.3 South America Albumin (as Excipient) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Albumin (as Excipient) Market Size by Country
  6. 10.2.1 South America Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Albumin (as Excipient) Market Size by Country (2021-2026)
  8. 10.2.3 South America Albumin (as Excipient) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Albumin (as Excipient) Sales by Country
  2. 11.1.1 Middle East and Africa Albumin (as Excipient) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Albumin (as Excipient) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Albumin (as Excipient) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Albumin (as Excipient) Market Size by Country
  6. 11.2.1 Middle East and Africa Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Albumin (as Excipient) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Albumin (as Excipient) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Albumin (as Excipient) Value Chain Analysis
  2. 12.1.1 Albumin (as Excipient) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Albumin (as Excipient) Production Mode & Process
  7. 12.2 Albumin (as Excipient) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Albumin (as Excipient) Distributors
  10. 12.2.3 Albumin (as Excipient) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst